Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes

This publication has 24 references indexed in Scilit:

• Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
  JAMA, 2000
• Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction
  Circulation, 2000
• C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction
  The American Journal of Cardiology, 1999
• Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability
  Circulation, 1999
• Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis
  Current Opinion in Lipidology, 1998
• Mast cell infiltration in acute coronary syndromes: implications for plaque rupture
  Journal of the American College of Cardiology, 1998
• Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 1998
• International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina
  Circulation, 1998
• A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina
  New England Journal of Medicine, 1998
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997